MEHANIL PLUS TABLETS

 ‘Adding Quality To Life’

Bridging Tradition and Modern Science for Evidence-Based Diabetes Care

Introduction

Mehanil Plus is a potent blend of natural ingredients, each contributing specific actions, synergistically formulated for the management of diabetes and its associated complications. It has been thoroughly analyzed through the lens of Ayurvedic principles (Karma) and emerging targets in Diabetes. It is scientifically validated using modern approaches, including computational studies, in-vitro, in-vivo models, network pharmacology, and clinical trials to support its efficacy in Type 2 Diabetes management.

GC-MS analysis identified 17 key components in Mehanil Plus, which modulated 17 out of 3,171 diabetes-associated proteins (as recorded in TTD and DisGeNET) with strong binding affinities and favourable ADME profiles. Docking studies revealed promising scores for Mehanil Plus components with targets such as  α-amylase, α-glucosidase, and pancreatic lipase. This was further supported by in-vitro enzymatic studies, demonstrating significant inhibitory effects on digestive enzymes (effect on carbohydrate and fat metabolism). These actions help control postprandial blood sugar levels (PPBS).

In vivo studies have shown that Mehanil Plus has a significant effect on reducing HbA1c levels, improving lipid parameters, and modulating Fructose-1,6-Bisphosphatase activity, a key mechanism in its mode of action. Clinically, it has been demonstrated to reduce HbA1c levels, improve fasting blood glucose levels, enhance patient compliance due to its natural and non-invasive formulation.

Mehanil Plus represents a comprehensive solution for diabetes management, combining evidence-based insights with traditional Ayurvedic wisdom.

Product Composition

Each tablet prepared out of:

Dosage: 1-2 tablets two to three times before food or as directed by the physician.

Benefits

Features

Evidence based overview of Mehanil plus  

Mehanil Plus supports maintaining a controlled blood glucose levels, combats oxidative stress, and aids in reducing diabetes related complications.

Mehanil Plus Action in Glucagon Signaling Pathway